ADAP
US Bancorp’s Adaptimmune Therapeutics ADAP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,058
| Closed | -$825 | – | 3942 |
|
2023
Q3 | $825 | Hold |
1,058
| – | – | ﹤0.01% | 3774 |
|
2023
Q2 | $979 | Buy |
+1,058
| New | +$979 | ﹤0.01% | 3776 |
|
2022
Q4 | – | Sell |
-16,049
| Closed | -$18K | – | 4107 |
|
2022
Q3 | $18K | Buy |
16,049
+14,939
| +1,346% | +$16.8K | ﹤0.01% | 3045 |
|
2022
Q2 | $2K | Sell |
1,110
-9,367
| -89% | -$16.9K | ﹤0.01% | 3763 |
|
2022
Q1 | $22K | Buy |
10,477
+6,028
| +135% | +$12.7K | ﹤0.01% | 2999 |
|
2021
Q4 | $17K | Sell |
4,449
-1,280
| -22% | -$4.89K | ﹤0.01% | 3170 |
|
2021
Q3 | $29K | Buy |
5,729
+4,590
| +403% | +$23.2K | ﹤0.01% | 2909 |
|
2021
Q2 | $5K | Sell |
1,139
-188
| -14% | -$825 | ﹤0.01% | 3569 |
|
2021
Q1 | $7K | Sell |
1,327
-109
| -8% | -$575 | ﹤0.01% | 3379 |
|
2020
Q4 | $7K | Sell |
1,436
-471
| -25% | -$2.3K | ﹤0.01% | 3268 |
|
2020
Q3 | $15K | Buy |
1,907
+549
| +40% | +$4.32K | ﹤0.01% | 2879 |
|
2020
Q2 | $14K | Sell |
1,358
-615
| -31% | -$6.34K | ﹤0.01% | 2903 |
|
2020
Q1 | $5K | Buy |
+1,973
| New | +$5K | ﹤0.01% | 3160 |
|